XML 50 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (Unaudited) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Jun. 30, 2012
Current Assets:    
Cash $ 124 $ 145
Accounts receivable, net 2,958 2,035
Inventories 6,493 5,290
Investment in iBio, Inc. - restricted 823 823
Other current assets 332 391
Total current assets 10,730 8,684
Intangible assets, net 1,085 1,154
Property and equipment, net 1,289 1,449
Security deposits and other assets 483 590
Total Assets 13,587 11,877
Current Liabilities:    
Advances under revolving credit facility 3,851 2,677
Accounts payable (includes $127 and $72 due to related party) 7,028 6,481
Accrued expenses and other current liabilities 1,438 1,549
Current portion of long term debt 875 1,496
Total current liabilities 13,192 12,203
Long term debt 5,093 4,698
Subordinated convertible note, net - CD Financial LLC 4,849 4,796
Derivative liabilities 991 563
Total liabilities 24,125 22,260
Commitments and Contingencies      
Stockholders' Deficiency:    
Common Stock, $0.002 par value; 50,000,000 shares authorized; 21,115,074 and 21,080,174 shares issued and outstanding, respectively 42 42
Additional paid-in capital 44,568 44,568
Accumulated deficit (55,049) (54,894)
Less: Treasury stock, at cost, 34,900 shares (99) (99)
Total Stockholders' Deficiency (10,538) (10,383)
Total Liabilities and Stockholders' Deficiency $ 13,587 $ 11,877